Inva2b1 Mouse

Disease model for psoriasis; in vivo study of human alpha2 and beta1 integrin transgene expression in skin.

Contributors

Inventor Institute
Fiona Watt Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Cat. #: 151551
Research Fields: Cell biology;Genetics
Target: Alpha2 intergrin, beta1 integrin
disease: Psoriasis
Zygosity: Heterozygous
Phenotype: Skin abnormalities (abnormal keratinocyte differentiation, hyperproliferation, inflammatory lesions)
Product description: Disease model for psoriasis; in vivo study of human alpha2 and beta1 integrin transgene expression in skin.
Conditional: Yes
Conditional description: Conditional expression of integrins under involucrin promoter giving tissue-specific suprabasal epidermal expression.
Genetic background: Involucrin – integrin transgene expression constructs were injected into fertilized oocytes from F1 hybrid CBAxC57Bl/6 mice. Transgene-positive mice were back-crossed to generate individual founder lines. alpha2 founder line was crossed with beta1 founder line to generate alpha2beta1 line.
Production details: Involucrin – integrin transgene expression constructs were injected into fertilized oocytes from F1 hybrid CBAxC57Bl/6 mice. Transgene-positive mice were back-crossed to generate individual founder lines. alpha2 founder line was crossed with beta1 founder line to generate alpha2beta1 line.
Additional notes: Mice present phenotype very similar to human psoriasis disease.
Shipping conditions: Embryo/Spermatoza- Dry Ice
References:

Carroll et al. 1995. Cell. 83(6):957-68. PMID: 8521519.

Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis.

Related Tools for Mouse models

Cat. # Tool Name
151443 GSTP1GSTP2 KO Mouse Key Info View Tool
151444 InvEE Mouse Key Info View Tool
151474 DR3-/- KO Mouse Key Info View Tool
151552 LFA1 -/- Mouse Key Info View Tool
151554 SAP1 Mouse Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.